Department of Internal Medicine, Temple University Hospital, Philadelphia, Pennsylvania, USA.
Department of Internal Medicine, Detroit Medical Center, Wayne State University, Detroit, Michigan, USA.
JACC Cardiovasc Interv. 2020 Dec 28;13(24):2896-2910. doi: 10.1016/j.jcin.2020.08.038.
Superior vena cava (SVC) syndrome comprises a constellation of clinical signs and symptoms caused by obstruction of blood flow through the SVC. The management of patients with life-threatening SVC syndrome is evolving from radiation therapy to endovascular therapy as the first-line treatment. There is a paucity of data and societal guidelines with regard to the management of SVC syndrome. This paper aims to update the practicing interventionalists with the contemporary and the evolving therapeutic approach to SVC syndrome. In addition, the review will focus on endovascular techniques, including catheter-directed thrombolysis, angioplasty, and stenting, and their associated complications.
上腔静脉（SVC）综合征是由 SVC 血流阻塞引起的一组临床症状和体征。由于危及生命的 SVC 综合征的治疗方法从放射治疗演变为血管内治疗作为一线治疗，因此有关 SVC 综合征的管理数据和社会指南非常有限。本文旨在为介入治疗医生提供 SVC 综合征的当代和不断发展的治疗方法的最新信息。此外，综述将重点介绍血管内技术，包括导管定向溶栓、血管成形术和支架置入术及其相关并发症。
